Direct Selling Self-Regulatory Council Refers ViSalus Claims to the FTC and California State Attorney General for Possible Enforcement Action
703.247.9330 / press@bbbnp.org
McLean, VA – December 22, 2022 – The Direct Selling Self-Regulatory Council (DSSRC) of BBB National Programs has referred direct selling company ViSalus, Inc. to the Federal Trade Commission (FTC) and California Office of the Attorney General for possible enforcement action. The referral comes after a lack of response from ViSalus to a DSSRC inquiry into aggressive earnings and health-related product performance claims made on social media by both ViSalus and its salesforce members.
DSSRC is an independent national advertising self-regulation program that monitors advertising and marketing claims in the direct selling industry. ViSalus is a multilevel marketing company that markets weight management nutritional products, dietary supplements, and energy drinks.
At issue are product performance claims indicating that ViSalus products can treat or provide relief for serious health-related conditions including diabetes, fibromyalgia, cancer, arthritis, and migraine headaches. The inquiry also included concerns regarding earnings claims conveying the message that participants in the ViSalus business opportunity can expect to earn significant or career-level income.
After multiple attempts via mail and phone, ViSalus has failed to respond to DSSRC’s inquiry and, pursuant to DSSRC Policies and Procedures, has now been referred to the FTC and the California Office of the Attorney General for possible enforcement action.
All BBB National Programs case decision summaries can be found in the case decision library. For full text of DSSRC decisions, visit the DSSRC Cases and Closures webpage.
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
National Advertising Division Recommends Dr. Luke Healthcare Discontinue Treatment Claims for its Fungal Nail Renewal Product
New York, NY – July 24, 2024 – The National Advertising Division recommended Dr. Luke Healthcare discontinue certain claims for Dr. Luke’s Fungal Nail Renewal product, including health-related claims, natural claims, and claims that a doctor recommends the product or that it treats a medical condition.
National Advertising Division Finds Flag Image on Kendamil Infant Formula Packaging Conveys Supported Message about Products’ Origin
New York, NY – July 17, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division determined that use of a flag image on product packaging for Kendal Nutricare’s Kendamil infant formula reasonably conveys a supported message about the products’ origin.
In National Advertising Division Case, GuruNanda Voluntarily Discontinues Claims Made through Influencers for Coconut Pulling Oil Products
New York, NY – July 16, 2024 – The National Advertising Division has closed a Fast-Track SWIFT challenge regarding claims that GuruNanda’s coconut pulling oil products can “naturally reverse a cavity” and “reverse cavities.”
National Advertising Division Refers Health-Related Advertising Claims for Prolacta’s Human Milk Fortifier to Regulatory Agencies
New York, NY – July 15, 2024 – The National Advertising Division will refer advertising claims made by Prolacta Bioscience for its Human Milk Fortifier to the Federal Trade Commission (FTC) and Food and Drug Administration (FDA) for review.